Point72 Asset Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-62,500
| Closed | -$28.1K | – | 1925 |
|
|
2024
Q1 | $28.1K | Hold |
62,500
| – | – | ﹤0.01% | 1368 |
|
|
2023
Q4 | $46.3K | Hold |
62,500
| – | – | ﹤0.01% | 1277 |
|
|
2023
Q3 | $54.4K | Hold |
62,500
| – | – | ﹤0.01% | 1429 |
|
|
2023
Q2 | $117K | Hold |
62,500
| – | – | ﹤0.01% | 1009 |
|
|
2023
Q1 | $231K | Hold |
62,500
| – | – | ﹤0.01% | 1016 |
|
|
2022
Q4 | $238K | Hold |
62,500
| – | – | ﹤0.01% | 896 |
|
|
2022
Q3 | $494K | Hold |
62,500
| – | – | ﹤0.01% | 898 |
|
|
2022
Q2 | $1.31M | Hold |
62,500
| – | – | 0.01% | 810 |
|
|
2022
Q1 | $2.35M | Hold |
62,500
| – | – | 0.01% | 772 |
|
|
2021
Q4 | $3.51M | Hold |
62,500
| – | – | 0.01% | 695 |
|
|
2021
Q3 | $4.51M | Hold |
62,500
| – | – | 0.02% | 636 |
|
|
2021
Q2 | $5.99M | Buy |
+62,500
| New | +$5.99M | 0.03% | 538 |
|